AP
NVO

Atwood & Palmer’s Novo Nordisk NVO Stock Holding History

Atwood & Palmer’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.2K Hold
400
– – ﹤0.01% 367
2026
Q2 		$19.2K Sell
400
-88
-18% -$3.78K ﹤0.01% 328
2026
Q1 		$17.9K Hold
488
– – ﹤0.01% 334
2025
Q4 		$24.8K Hold
488
– – ﹤0.01% 304
2025
Q3 		$27.1K Sell
488
-249
-34% -$14.6K ﹤0.01% 303
2025
Q2 		$50.9K Buy
737
+178
+32% +$12.1K ﹤0.01% 240
2025
Q1 		$38.8K Hold
559
– – ﹤0.01% 241
2024
Q4 		$48.1K Hold
559
– – ﹤0.01% 221
2024
Q3 		$66.6K Sell
559
-22
-4% -$2.93K ﹤0.01% 207
2024
Q2 		$82.9K Buy
581
+181
+45% +$24K 0.01% 199
2024
Q1 		$51.4K Hold
400
– – ﹤0.01% 210
2023
Q4 		$41.4K Buy
400
+150
+60% +$14.8K ﹤0.01% 232
2023
Q3 		$22.7K Buy
+250
New +$22K ﹤0.01% 264
2017
Q4 		– Sell
-8,800
Closed -$212K – 300
2017
Q3 		$212K Sell
8,800
-1,300
-13% -$29.4K 0.03% 125
2017
Q2 		$217K Sell
10,100
-64,784
-87% -$1.31M 0.03% 122
2017
Q1 		$1.28M Sell
74,884
-327,852
-81% -$5.71M 0.21% 57
2016
Q4 		$7.22M Sell
402,736
-88,650
-18% -$1.61M 1.3% 28
2016
Q3 		$10.2M Sell
491,386
-1,380
-0.3% -$34.2K 1.86% 22
2016
Q2 		$13.3M Buy
492,766
+21,900
+5% +$601K 2.39% 17
2016
Q1 		$12.8M Buy
470,866
+470,036
+56,631% +$12.6M 2.27% 19
2015
Q4 		$24K Hold
830
– – ﹤0.01% 258
2015
Q3 		$23K Buy
830
+600
+261% +$17K ﹤0.01% 255
2015
Q2 		$6K Buy
+230
New +$6.47K ﹤0.01% 324

Other funds holding NVO

GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
MCP
Martin Capital Partners Eugene, Oregon $279M AUM 18.87% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EIA
Eastover Investment Advisors Charlotte, North Carolina $257M AUM 14.8% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
NFGCM
Norman Fields Gottscho Capital Management New York $329M AUM 22.06% 1-Year Est. Return
BFA
Benedict Financial Advisors Atlanta, Georgia $504M AUM 20.67% 1-Year Est. Return
HWA
Heartwood Wealth Advisors Richmond, Virginia $1.27B AUM 11.08% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM

Atwood & Palmer's NVO Position: Q3 2026 in Review

Atwood & Palmer held its Novo Nordisk (NVO) position steady in Q3 2026 at 400 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #367.

Atwood & Palmer first reported a position in NVO in Q2 2015 and has held it in 23 quarters since. The position peaked at $13.3M in Q2 2016. 64 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Atwood & Palmer held 400 shares of Novo Nordisk worth $15.2K as of Q3 2026.
  • Atwood & Palmer left its Novo Nordisk share count unchanged in Q3 2026.
  • Novo Nordisk made up ﹤0.01% of Atwood & Palmer's portfolio in Q3 2026, its #367 holding.
  • Atwood & Palmer first reported a position in Novo Nordisk in Q2 2015 and has held it in 23 quarters since.
  • Atwood & Palmer's Novo Nordisk position peaked at $13.3M in Q2 2016.
  • 64 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Atwood & Palmer's 13F filing for Q3 2026, filed 8 Oct 2026.